In 1970, the United States Controlled Substance Act listed cannabis as a schedule 1 substance, defined by the Drug Enforcement Administration as lacking medical benefits or safety profile and having a high potential for abuse. However, the legal status of cannabis is rapidly changing in the United States, with important implications for public health and physician practice. Most states in US have now legalized cannabis use for medical conditions, and some states have legalized cannabis for adult recreation. Although cannabis shows therapeutic promise in some areas, cannabis use for various medical conditions is rampant despite lack of scientific evidence. Psychiatric patients are particularly vulnerable to the negative effects of cannabis use.

ATTENDANCE / CREDIT

Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.